Health
Researchers analyzing over 2,500 individuals found that antibiotics, antidepressants, beta-blockers, proton-pump inhibitors, and benzodiazepines leave persistent, drug-specific imprints on the gut microbiome—effects detectable years after discontinuation.

Scientists have identified that numerous medications induce near-permanent alterations to the gut microbiota, with traces of their use remaining detectable in the microbiome years after patients stop taking them.
A study published in the journal mSystems examined data from more than 2,500 people. Researchers observed that antibiotics—as well as antidepressants, beta-blockers, proton-pump inhibitors, and benzodiazepines—each leave a distinct, enduring signature on the gut microbial community.
The findings proved especially surprising for benzodiazepines. Their impact on gut bacteria mirrored that of broad-spectrum antibiotics. Moreover, even drugs classified within the same therapeutic category produced divergent microbiome effects: diazepam and alprazolam, for instance, triggered different microbial shifts despite being routinely grouped together.
Multiple independent analytical runs confirmed the reliability of these observations. The microbiome responded predictably—shifting in expected directions—when participants initiated or discontinued specific medications.
Investigators from the Institute of Genomics at the University of Tartu in Estonia emphasized the critical importance of this finding for scientific research. When analyzing an individual’s microbiome, researchers must account for the person’s complete medication history; otherwise, conclusions risk inaccuracy.
The gut microbiome contributes to digestion, immune function, and metabolism. Persistent changes induced by medications could therefore carry long-term health consequences. Scientists stress, however, that the observed associations reflect specific correlations—not proven harm—and that patients should not discontinue prescribed medications based on these results.



